China Proton Therapy Market Size, Status and Forecast to 2025
Date: Dec-2018 | Id: MACRC-0089 | Geographical Scope: China | Publisher: DPI Research
“China Proton Therapy Market Size, Status and Forecast to 2025” examines the market dynamics, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in China. The research includes historic data from 2015 to 2017 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. The report provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.The report further sheds light on the number of treatment rooms,current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at China proton therapy centers from 2008 to 2016. The report also includes assessment of China reimbursement scenario; proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the China proton therapy market. The report concludes with the profiles of major players in the China proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, China proton therapy centers developed by the companies and recent development of the proton therapy market. The major companies dominating this market for its products, services and continuous product developments are: Advanced Oncotherapy, Siemens Healthneers, ProNova Solution, ProTom International, Hitachi, Ion Beam Applications (IBA), Varian Medical Systems, Mevion Medical Systems Long–term Growth Projection: • China represents a significant opportunity in the Global proton therapy market • China proton therapy market will exhibit a steady CAGR of over 30% by 2025 • The potential China proton therapy market is likely to reach more than USD 10 Billion by 2025 • IBA accounted highest number of proton therapy centers in the forecast period • Advanced Oncotherapy is emerging with novel technology and significantly impacting the proton therapy market size over the forecast period The Latest Industry Data Included in this Report: • Proton Therapy Current Applications • Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy • Proton Therapy Competitive Analysis by Company • China Proton Therapy Market Size & Analysis (2015 – 2025) • China Proton Therapy Market Opportunity Assessment (2012 – 2025) • China Number of Treatment Rooms and Forecast (2017 – 2025) • China Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator • China Number of Patients Treated at Proton Therapy Centers (2008 – 2016) • China Proton Therapy Reimbursement Scenario • Proton Therapy Center Component Analysis • Proton Therapy Clinical Trail Insight by Phase, Institute & Country • Major Deals in Proton Therapy Market • Key Market Drivers and Inhibitors of the China Proton Therapy Market • Major Companies Analysis Key Deliverables in the Study • Market Definition for the specified topic along with identification of key drivers and inhibitors for the market • Trending factors influencing the market of the China proton therapy market • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments • It provides a seven-year forecast which helps to provide a long-term assessment of developments in the China proton therapy market • Identification and analysis of the macro and micro factors that affect the China proton therapy market • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities • A comprehensive list of key market players along with the analysis of their current product portfolios and recent development
1. Executive Summary 2. What is Proton Therapy? 3. Proton Therapy Current Applications 4. Proton Therapy Comparative Analysis 4.1 Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy 4.2 Proton Therapy Competitive Analysis: By Company 5. China Proton Therapy Market Size & Analysis (2015 – 2025) 5.1 Proton Therapy Patients Treated Statistics (Volume) 5.2 Proton Therapy Market Analysis (Value) 6. China Proton Therapy Market Opportunity Assessment (2012 – 2025) 6.1 Potential Proton Therapy Patient Base (Volume) 6.2 Potential Proton Therapy Market Demand Analysis (Value) 7. Key Market Drivers and Inhibitors of the China Proton Therapy Market 7.1 Market Drivers 7.2 Market Inhibitors 8. China Number of Treatment Rooms and Forecast (2017 – 2025) 9. China Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator 9.1 Current Proton Therapy Centers 9.2 Demand for Proton Therapy Centers 10. China Number of Patients Treated at Proton Therapy Centers 11. China Proton Therapy Reimbursement Scenario 12. Proton Therapy Center Component Analysis 13. Proton Therapy Clinical Trail Insight by Phase, Institute & Country 13.1 Year 2018 13.2 Year 2017 14. Major Deals in Proton Therapy Market 14.1 Collaboration Deals 14.2 Licensing Agreement 14.3 Exclusive Agreement 14.4 Partnership Deals 14.5 Venture Capital Investment 14.6 Development Agreement 15. Key Companies Analysis 15.1 Ion Beam Applications (IBA) 15.1.1 Company Overview 15.1.2 Product Portfolios 15.1.3 China Proton Therapy Centers Developed and Under Construction by IBA 15.1.4 Recent Development 15.2 Hitachi 15.2.1 Company Overview 15.2.2 Product Portfolios 15.2.3 China Proton Therapy Centers Planning by Hitachi 15.2.4 Recent Development 15.3 Varian Medical Systems 15.3.1 Company Overview 15.3.2 Product Portfolios 15.3.3 China Proton Therapy Centers Under Construction by Varian 15.3.4 Recent Development 15.4 ProNova Solution (Provision Healthcare) 15.4.1 Business Overview 15.4.2 Product Portfolios 15.4.3 China Proton Therapy Centers Planning by ProNova Solutions 15.4.4 Recent Development 15.5 ProTom International 15.5.1 Business Overview 15.5.2 Product Portfolios 15.5.3 China Proton Therapy Centers Planning by ProTom International 15.5.4 Recent Development 15.6 Mevion Medical Systems 15.6.1 Company Overview 15.6.2 Product Portfolios 15.6.3 China Proton Therapy Centers Planning by Mevion 15.6.4 Recent Development 15.7 Siemens Healthneers 15.7.1 Company Overview 15.7.2 Product Portfolios 15.7.3 China Proton Therapy Centers Developed by Siemens Healthneers 15.7.4 Recent Development 15.8 Advanced Oncotherapy 15.8.1 Company Overview 15.8.2 Product Portfolios 15.8.3 Recent Development
Related reports
Early Cardiogenic Shock Devices
$4500-$6600